AltMountain

Farallon Capital Management, L.L.C.

San Francisco, CA · CRD 107322
Hedge fund manager

Farallon Capital Management, L.L.C. is an SEC-registered investment adviser based in San Francisco, CA that reports managing 50 hedge funds on Form ADV. It reports $52.1 billion in regulatory assets under management. Its private funds, of all types, hold $64.5 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +16.2% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +49.1% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$52.1 billionForm ADV Item 5.F
Gross assets of private funds
$64.5 billionAll private fund types, Form ADV
Hedge funds managed
5050 private funds in total
Employees
355Form ADV Item 5.A
Registration
SEC-registered adviserCRD 107322
Latest Form ADV
09/23/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.

Estimated from 13F · 2026 YTD+16.2%Through Q2 2026 · S&P 500 +9.5%
Estimated from 13F · 2 years+49.1%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$16.9 billion82 positions, 2026-06-30
$100$125$149Q3 2024Q1 2025Q3 2025Q1 202613F est. $149S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+23.6%+14.8%
Q1 2026-6.1%-4.6%
Q4 2025+8.0%+2.4%
Q3 2025+4.7%+7.8%
Q2 2025+6.8%+10.4%
Q1 2025-4.2%-4.5%
Q4 2024-0.3%+2.1%
Q3 2024+11.3%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.

13F holdings as of Sep 30, 2026

The 50 largest of 110 share positions ($18,657,509,328) reported by Farallon Capital Management, L.L.C. on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.

Share of the reported 13F portfolio, ten largest positions

  • Revolution Medicines Inc14.76%
  • Warner Bros Discovery Inc8.19%
  • Natera Inc5.76%
  • Bridgebio Pharma Inc5.02%
  • Protagonist Therapeutics Inc4.86%
  • Exelixis Inc4.60%
  • Roivant Sciences LTD4.26%
  • Roku Inc3.40%
  • Amazon Com Inc3.16%
  • Grail Inc3.06%
StockValue% of 13F portfolioSharesShares vs prior quarter
Revolution Medicines Inc$2,754,342,06714.76%13,418,796-0.97%
Warner Bros Discovery Inc$1,528,074,0478.19%49,372,344New
Natera Inc$1,074,460,5155.76%2,599,648+17.19%
Bridgebio Pharma Inc$937,452,6005.02%14,247,000+32.62%
Protagonist Therapeutics Inc$907,036,5764.86%6,437,906+1.40%
Exelixis Inc$858,329,6934.60%14,694,910+9.11%
Roivant Sciences LTD$795,234,1424.26%21,745,533+51.97%
Roku Inc$633,492,2623.40%4,160,049New
Amazon Com Inc$590,102,8063.16%2,368,464-10.05%
Grail Inc$570,180,9283.06%4,069,233-2.22%
Boston Scientific Corp$492,684,7092.64%11,287,164+7.28%
Broadcom Inc$490,194,5142.63%1,395,810+21.19%
CRH PLC$442,243,0802.37%5,341,100New
Kenvue Inc$441,764,9002.37%25,015,000New
Twist Bioscience Corp$412,837,9362.21%2,136,400Unchanged
Unitedhealth Group Inc$384,928,1642.06%1,048,622-17.47%
Microsoft Corp$376,244,4632.02%733,563-34.08%
Synopsys Inc$373,130,6772.00%857,890+3.41%
KKR & Co Inc$354,245,8261.90%3,880,020-5.79%
Aon PLC$343,104,0191.84%1,239,672-10.34%
Lantheus Hldgs Inc$309,663,1111.66%3,111,254-44.28%
Thermo Fisher Scientific Inc$300,859,6591.61%445,685-57.52%
Liquidia Corporation$269,496,7101.44%8,906,038+6.47%
Wabtec$252,116,1841.35%877,903-1.86%
Beam Therapeutics Inc$251,257,8821.35%10,276,396+0.39%
Aramark$246,674,3801.32%4,606,431+27.05%
Immunovant Inc$218,590,3801.17%6,471,000+11.47%
Agios Pharmaceuticals Inc$197,485,0501.06%5,939,400+0.37%
Biogen Inc$153,794,4640.82%680,868+858.97%
Johnson & Johnson$127,187,9790.68%480,426+17.75%
Acadia Healthcare Company In$126,731,0000.68%4,608,400+9.18%
Brightspring Health Svcs Inc$115,985,6500.62%2,043,800+17.95%
Tango Therapeutics Inc$113,539,6660.61%4,550,688-62.93%
Baidu Inc$104,572,8030.56%1,203,785Unchanged
American Svgs BK Na$81,526,1970.44%4,557,082New
Parabilis Medicines Inc$76,469,1780.41%2,368,200Unchanged
Astrazeneca PLC$71,046,8000.38%440,000-23.34%
Joyy Inc$65,821,0500.35%820,200+17.31%
Avalo Therapeutics Inc$60,921,4200.33%3,974,000+59.09%
Freenome Inc$58,806,6730.32%3,733,757New
Ionic Digital Inc$57,686,8210.31%718,123New
Guardant Health Inc$49,887,2920.27%279,700-13.19%
Assembly Biosciences Inc$37,691,8190.20%1,604,590Unchanged
Novartis AG$36,355,3500.19%255,000-29.75%
Maze Therapeutics Inc$30,110,3850.16%1,107,814Unchanged
LB Pharmaceuticals Inc$28,455,3160.15%741,410New
Immunocore Hldgs PLC$28,109,1200.15%928,000New
Asml Hldg NV$24,490,1550.13%13,518New
Rio Tinto PLC$20,613,7190.11%218,899+19.31%
Alibaba Group Hldg LTD$20,325,0600.11%189,000New

Changes since Jun 30, 2026

Comparing the share counts in the two quarter-end filings: 48 new positions, 20 sold out, 22 increased, 19 reduced and 21 unchanged.

Number of positions (a count, not dollars)

  • New positions48
  • Increased22
  • Unchanged21
  • Reduced19
  • Sold out20

New positions

StockValueShares
Warner Bros Discovery Inc$1,528,074,04749,372,344
Roku Inc$633,492,2624,160,049
CRH PLC$442,243,0805,341,100
Kenvue Inc$441,764,90025,015,000
American Svgs BK Na$81,526,1974,557,082
Freenome Inc$58,806,6733,733,757
Ionic Digital Inc$57,686,821718,123
LB Pharmaceuticals Inc$28,455,316741,410
Immunocore Hldgs PLC$28,109,120928,000
Asml Hldg NV$24,490,15513,518
Alibaba Group Hldg LTD$20,325,060189,000
Electra Therapeutics Inc$19,125,0001,700,000
Indivior Pharmaceuticals Inc$16,047,177447,620
Latigo Biotrapeutics Inc$14,195,000850,000
Scribe Therapeutics Inc$6,993,900380,000
Cohu Inc$6,200,74091,000
Entegris Inc$5,700,22037,000
Braveheart Bio Inc$5,611,116277,778
Celestica Inc$5,421,45015,000
Revvity Inc$5,351,15035,000

Sold out

StockValue at Jun 30, 2026Shares held then
Electronic Arts Inc$1,623,814,2807,919,500
Crinetics Pharmaceuticals In$336,372,0478,989,098
Novo-nordisk A S$125,554,8602,619,000
Merck & Co Inc$25,571,500199,000
Warby Parker Inc$25,121,520828,000
Perceptive Cap Solutions Cor$24,480,0002,250,000
Axalta Coating SYS LTD$16,357,160478,000
Beta Bionics Inc$9,323,650595,000
Scotts Miracle-gro Co$5,993,68088,000
Waystar Hldg Corp$5,438,397264,900
Brunswick Corp$5,138,64061,000
Gentex Corp$5,028,730199,000
Idexx Labs Inc$4,737,9609,000
Commercial Metals Co$4,204,25067,000
Teva Pharmaceutical Inds LTD$1,355,20040,000
Aleanna Inc$297,000990,000
Aleanna Inc$227,36078,400
Solid Power Inc$41,423405,316
Blue Gold LTD$30,696255,800
Beyond Meat Inc$14,25019,000

Largest increases

StockChange in sharesChangeValue nowShares now
Roivant Sciences LTD+7,436,533+51.97%$795,234,14221,745,533
Bridgebio Pharma Inc+3,503,937+32.62%$937,452,60014,247,000
Natera Inc+381,282+17.19%$1,074,460,5152,599,648
Biogen Inc+609,868+858.97%$153,794,464680,868
Broadcom Inc+244,010+21.19%$490,194,5141,395,810
Exelixis Inc+1,226,900+9.11%$858,329,69314,694,910
Aramark+980,700+27.05%$246,674,3804,606,431
Boston Scientific Corp+765,980+7.28%$492,684,70911,287,164
Avalo Therapeutics Inc+1,476,000+59.09%$60,921,4203,974,000
Immunovant Inc+666,000+11.47%$218,590,3806,471,000
Johnson & Johnson+72,426+17.75%$127,187,979480,426
Brightspring Health Svcs Inc+311,000+17.95%$115,985,6502,043,800
Liquidia Corporation+541,000+6.47%$269,496,7108,906,038
Protagonist Therapeutics Inc+89,000+1.40%$907,036,5766,437,906
Synopsys Inc+28,290+3.41%$373,130,677857,890
Acadia Healthcare Company In+387,600+9.18%$126,731,0004,608,400
Joyy Inc+121,000+17.31%$65,821,050820,200
Rio Tinto PLC+35,424+19.31%$20,613,719218,899
Abivax SA+18,000+14.75%$13,862,800140,000
Beam Therapeutics Inc+40,000+0.39%$251,257,88210,276,396

Largest reductions

StockChange in sharesChangeValue nowShares now
Thermo Fisher Scientific Inc-603,500-57.52%$300,859,659445,685
Lantheus Hldgs Inc-2,472,225-44.28%$309,663,1113,111,254
Microsoft Corp-379,300-34.08%$376,244,463733,563
Tango Therapeutics Inc-7,726,312-62.93%$113,539,6664,550,688
Unitedhealth Group Inc-221,910-17.47%$384,928,1641,048,622
Amazon Com Inc-264,530-10.05%$590,102,8062,368,464
Aon PLC-142,890-10.34%$343,104,0191,239,672
Revolution Medicines Inc-132,000-0.97%$2,754,342,06713,418,796
KKR & Co Inc-238,280-5.79%$354,245,8263,880,020
Astrazeneca PLC-134,000-23.34%$71,046,800440,000
Enanta Pharmaceuticals Inc-1,468,202-60.71%$12,521,000950,000
Novartis AG-108,000-29.75%$36,355,350255,000
Grail Inc-92,351-2.22%$570,180,9284,069,233
Guardant Health Inc-42,500-13.19%$49,887,292279,700
Mobia Med Inc-690,729-61.20%$4,137,475437,828
Wabtec-16,600-1.86%$252,116,184877,903
Sagimet Biosciences Inc-15,000-3.61%$3,952,000400,000
Inflarx NV-15,000-0.45%$5,958,0003,310,000
Nvni Group Limited-43,600-11.63%$5,700331,400

Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.

From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures

Large ownership stakes (Schedule 13D and 13G)

CompanyFilingPercent of classSharesFiledSource
Tango Therapeutics, Inc.13G amendment4.9%8,543,875Nov 16, 2026SEC.gov ↗
Lantheus Holdings, Inc.13G amendment4.8%3,111,254Nov 16, 2026SEC.gov ↗
Enanta Pharmaceuticals Inc13G amendment3.3%950,000Nov 16, 2026SEC.gov ↗
Avalo Therapeutics, Inc.13G7.4%3,974,000Nov 13, 2026SEC.gov ↗
Crinetics Pharmaceuticals, Inc.13G amendment0%0Nov 12, 2026SEC.gov ↗
BridgeBio Pharma, Inc.13G amendment7.3%14,247,000Nov 12, 2026SEC.gov ↗
Exelixis, Inc.13G6%14,694,910Nov 9, 2026SEC.gov ↗
Tyra Biosciences, Inc.13G amendment0%6,000Aug 14, 2026SEC.gov ↗
Savara Inc.13G amendment6.8%15,000,000Aug 14, 2026SEC.gov ↗
InflaRx N.V.13G amendment2.3%3,325,000Aug 14, 2026SEC.gov ↗
Revolution Medicines, Inc.13G amendment6.4%13,564,149Aug 13, 2026SEC.gov ↗
Protagonist Therapeutics, Inc.13G amendment9.99%6,433,119Aug 13, 2026SEC.gov ↗
Minerva Neurosciences, Inc.13G amendment9.7%4,730,000Aug 13, 2026SEC.gov ↗
GRAIL, Inc.13G amendment9.6%4,161,584Aug 13, 2026SEC.gov ↗
Beam Therapeutics Inc.13G amendment9.99%10,282,210Aug 13, 2026SEC.gov ↗

A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Jun 26, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Showing the 15 most recent of 20 companies. Source: U.S. Securities and Exchange Commission, EDGAR.

Hedge funds filing Form D (11)

Fund
First sale
Raised
Investors
Minimum
YTD · manager-reported
Farallon Capital Institutional Partners, L.P.
San Francisco, CA
First saleJan 1990
Raised$11B
Investors530
MinimumNone set
YTD · manager-reportedNot reported
Farallon Capital Partners, L.P.
San Francisco, CA
First saleJan 1990
Raised$8.4B
Investors874
MinimumNone set
YTD · manager-reportedNot reported
Farallon Capital Offshore Investors, Inc.
Camana Bay, Grand Cayman, Cayman IslandsOffshore
First saleDec 1996
Raised$4.0B
Investors185
MinimumNone set
YTD · manager-reportedNot reported
Farallon Equity Partners, L.P.
San Francisco, CA
First saleJan 2016
Raised$3.1B
Investors140
MinimumNone set
YTD · manager-reportedNot reported
Farallon Capital F5 Investors I, L.P.
San Francisco, CA
First saleJul 2015
Raised$1.1B
Investors66
MinimumNone set
YTD · manager-reportedNot reported
Farallon Healthcare Partners International, Ltd.
Camana Bay, Grand Cayman, Cayman IslandsOffshore
First saleJul 2021
Raised$952M
Investors39
Minimum$100K
YTD · manager-reportedNot reported
Farallon Equity Partners International, Ltd.
Camana Bay, Grand Cayman, Cayman IslandsOffshore
First saleJan 2016
Raised$950M
Investors47
Minimum$100K
YTD · manager-reportedNot reported
Farallon Healthcare Partners, L.P.
San Francisco, CA
First saleJul 2021
Raised$651M
Investors59
MinimumNone set
YTD · manager-reportedNot reported
Farallon Capital F5 Investors II, L.P.
San Francisco, CA
First saleJul 2015
Raised$240M
Investors46
MinimumNone set
YTD · manager-reportedNot reported
Farallon Capital (AM) Investors, L.P.
San Francisco, CA
First saleSep 2010
Raised$130M
Investors1
MinimumNone set
YTD · manager-reportedNot reported
Farallon Investment Holdings, L.P.
San Francisco, CA
First saleJul 2007
Raised$51.5M
Investors80
MinimumNone set
YTD · manager-reportedNot reported

Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.

Private investment funds filing Form D (1)

Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.

Private funds reported on Form ADV (45)

Fund
Gross assets
Minimum
Owners
Adviser
Farallon Capital Offshore Investors II, L.P.
Cayman IslandsHedge fund
Gross assets$10B
MinimumNone set
Owners364
AdviserFarallon Capital Management, L.L.C.
Farallon Equity Partners Master, L.P.
Cayman IslandsHedge fund
Gross assets$6.9B
Minimum$5.0M
Owners178
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Institutional Partners, L.P.
California, United StatesHedge fund
Gross assets$6.1B
Minimum$5.0M
Owners437
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Partners, L.P.
California, United StatesHedge fund
Gross assets$4.6B
Minimum$5.0M
Owners665
AdviserFarallon Capital Management, L.L.C.
Farallon Healthcare Partners Master, L.P.
Cayman IslandsHedge fund
Gross assets$2.1B
Minimum$5.0M
Owners65
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Institutional Partners II, L.P.
California, United StatesHedge fund
Gross assets$1.8B
MinimumNone set
Owners3
AdviserFarallon Capital Management, L.L.C.
Farallon Capital F5 Master I, L.P.
Cayman IslandsHedge fund
Gross assets$1.7B
Minimum$5.0M
Owners104
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master Fund II, L.P.
Cayman IslandsHedge fund
Gross assets$1.6B
Minimum$10.0M
Owners94
AdviserFarallon Capital Management, L.L.C.
Four Crossings Institutional Partners V, L.P.
Delaware, United StatesHedge fund
Gross assets$1.0B
MinimumNone set
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Institutional Partners III, L.P.
Delaware, United StatesHedge fund
Gross assets$911M
MinimumNone set
Owners4
AdviserFarallon Capital Management, L.L.C.
Farallon Asia Special Situations Master III, L.P.
Cayman IslandsHedge fund
Gross assets$614M
Minimum$10.0M
Owners60
AdviserFarallon Capital Management, L.L.C.
Farallon Capital (Am) Investors, L.P.
Delaware, United StatesHedge fund
Gross assets$586M
MinimumNone set
Owners3
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master Fund III Non-Us, L.P.
Cayman IslandsHedge fund
Gross assets$584M
Minimum$10.0M
Owners29
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master VII, L.P.
Delaware, United StatesHedge fund
Gross assets$544M
Minimum$150M
Owners3
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master Fund, L.P.
Cayman IslandsHedge fund
Gross assets$493M
Minimum$10.0M
Owners62
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Institutional Partners IV, L.P.
Delaware, United StatesHedge fund
Gross assets$415M
Minimum$5.0M
Owners25
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master Credit IX, L.P.
Cayman IslandsHedge fund
Gross assets$376M
Minimum$250M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Octave, L.P.
Delaware, United StatesHedge fund
Gross assets$374M
Minimum$300M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Institutional Partners III, L.P.
Delaware, United StatesHedge fund
Gross assets$299M
Minimum$5.0M
Owners28
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master X-VII, L.P.
Delaware, United StatesHedge fund
Gross assets$268M
Minimum$250M
Owners3
AdviserFarallon Capital Management, L.L.C.
Farallon Asia Special Situations Master II, L.P.
Cayman IslandsHedge fund
Gross assets$213M
Minimum$20.0M
Owners75
AdviserFarallon Capital Management, L.L.C.
Farallon Overflow Fund, L.P.
Delaware, United StatesHedge fund
Gross assets$210M
Minimum$60.0M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Partners IV, L.P.
Delaware, United StatesHedge fund
Gross assets$180M
Minimum$5.0M
Owners37
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Institutional Partners II, L.P.
Delaware, United StatesHedge fund
Gross assets$128M
Minimum$5.0M
Owners17
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situation Partners VI, L.P.
Delaware, United StatesHedge fund
Gross assets$109M
Minimum$40.0M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Partners III, L.P.
Delaware, United StatesHedge fund
Gross assets$97.2M
Minimum$5.0M
Owners29
AdviserFarallon Capital Management, L.L.C.
Farallon Special Investment Institutional Partners IV, L.P.
Delaware, United StatesHedge fund
Gross assets$95.5M
Minimum$5.0M
Owners10
AdviserFarallon Capital Management, L.L.C.
Farallon Asia Special Situations Master, L.P.
Cayman IslandsHedge fund
Gross assets$91.3M
Minimum$20.0M
Owners44
AdviserFarallon Capital Management, L.L.C.
Farallon Special Investment Partners III, L.P.
Delaware, United StatesHedge fund
Gross assets$89.3M
Minimum$52.2M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Overflow Master Fund II, L.P.
Cayman IslandsHedge fund
Gross assets$78.2M
Minimum$30.0M
Owners3
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Aa Investors, L.P.
Delaware, United StatesHedge fund
Gross assets$77.8M
MinimumNone set
Owners8
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situation Partners IV, L.P.
Cayman IslandsHedge fund
Gross assets$50.9M
Minimum$50.0M
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Institutional Partners, L.P.
Delaware, United StatesHedge fund
Gross assets$46.3M
Minimum$5.0M
Owners14
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Partners II, L.P.
Delaware, United StatesHedge fund
Gross assets$29.8M
Minimum$5.0M
Owners23
AdviserFarallon Capital Management, L.L.C.
Farallon Investment Holdings, L.P.
Delaware, United StatesHedge fund
Gross assets$29.7M
Minimum$50K
Owners41
AdviserFarallon Capital Management, L.L.C.
Farallon Real Estate Partners, L.P.
Delaware, United StatesHedge fund
Gross assets$14.6M
Minimum$5.0M
Owners23
AdviserFarallon Capital Management, L.L.C.
Farallon Special Investment Partners, L.P.
Delaware, United StatesHedge fund
Gross assets$6.8M
Minimum$50.0M
Owners6
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situation Partners Master III, L.P.
Cayman IslandsHedge fund
Gross assets$5.2M
MinimumNone set
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Institutional Partners 2.5, L.P.
Delaware, United StatesHedge fund
Gross assets$3.9M
MinimumNone set
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situation Partners V, L.P.
Cayman IslandsHedge fund
Gross assets$2.9M
MinimumNone set
Owners2
AdviserFarallon Capital Management, L.L.C.
RR Capital Partners, L.P.
Delaware, United StatesHedge fund
Gross assets$2.2M
MinimumNone set
Owners4
AdviserFarallon Capital Management, L.L.C.
Noonday Capital Partners, L.L.C.
Delaware, United StatesHedge fund
Gross assets$512K
Minimum$1.0M
Owners5
AdviserFarallon Capital Management, L.L.C.
Tinicum Partners, L.P.
New York, United StatesHedge fund
Gross assets$286K
Minimum$2.5M
Owners4
AdviserFarallon Capital Management, L.L.C.
Farallon Capital F5 Master II, L.P.
Delaware, United StatesHedge fund
Gross assets$0
Minimum$5.0M
Owners98
AdviserFarallon Capital Management, L.L.C.
Farallon Special Situations Master Fund III US, L.P.
Delaware, United StatesHedge fund
Gross assets$0
Minimum$10.0M
Owners29
AdviserFarallon Capital Management, L.L.C.

As reported in the adviser's Form ADV filed Oct 30, 2024. Funds also listed from Form D are shown above.

Fund vehicles: feeder funds and single-deal vehicles (9)

Fund
Gross assets
Minimum
Owners
Adviser
Fcoi II Holdings, L.P.
Cayman IslandsHedge fund
Gross assets$4.7B
Minimum$5.0M
Owners210
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Offshore Investors, Inc. - Investing Classes
British Virgin IslandsHedge fund
Gross assets$2.0B
Minimum$5.0M
Owners91
AdviserFarallon Capital Management, L.L.C.
Fcoi II Currency Class Fund, LTD.
Cayman IslandsHedge fund
Gross assets$1.4B
Minimum$50.0M
Owners58
AdviserFarallon Capital Management, L.L.C.
Farallon Capital F5 Investors I, L.P.
Cayman IslandsHedge fund
Gross assets$1.0B
Minimum$5.0M
Owners59
AdviserFarallon Capital Management, L.L.C.
Farallon Capital Institutional Partners VI, L.P.
Cayman IslandsHedge fund
Gross assets$768M
MinimumNone set
Owners2
AdviserFarallon Capital Management, L.L.C.
Farallon Capital F5 Cc, L.P.
Cayman IslandsHedge fund
Gross assets$276M
Minimum$5.0M
Owners6
AdviserFarallon Capital Management, L.L.C.
Farallon Capital F5 Investors II, L.P.
Delaware, United StatesHedge fund
Gross assets$202M
Minimum$5.0M
Owners39
AdviserFarallon Capital Management, L.L.C.
Farallon Co-Investment Master Fund, L.P.
Cayman IslandsHedge fund
Gross assets$48.6M
MinimumNone set
Owners3
AdviserFarallon Capital Management, L.L.C.
Sidecar Partners, L.P.
Cayman IslandsHedge fund
Gross assets$11.6M
Minimum$50.0M
Owners29
AdviserFarallon Capital Management, L.L.C.

Feeder funds invest through a master fund; single-deal vehicles (SPVs, co-investments, series) hold one investment.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠